If you have not learned about Exparel WHY!
When communicating with patients about your approach to reducing their exposure to opioids, use the messages below. Each message takes a slightly different approach to explain how EXPAREL® (bupivacaine liposome injectable suspension) can help improve patients’ postsurgical pain management while reducing opioid use.* The Indication, opioid disclaimer, and Important Safety Information provided will need to accompany each message if used in any print or digital communications.
[Patient opioid concerns]
If you have concerns about using opioids to manage your pain after surgery, there are non-addictive options, such as EXPAREL® (bupivacaine liposome injectable suspension), that can be effective. EXPAREL is a non-opioid alternative that provides long-lasting pain control for the first few days after surgery, when you need it most. EXPAREL has been proven to help reduce your need for other pain medications, such as opioids.* Contact me to discuss a pain management plan that is right for you. Visit www.EXPAREL.com/patient for more information.
[Patient pain concerns]
Your concerns about pain after surgery are important to me and I want you to know that I have options available to ensure your pain is well controlled. I use EXPAREL® (bupivacaine liposome injectable suspension), a non-addictive medication, to provide long-lasting pain control directly at the surgical site. This can help reduce the need for other pain medications, such as opioids.* Contact me to discuss a pain management plan that is right for you. Visit www.EXPAREL.com/patient for more information.
[Tailored pain management]
Every patient’s pain experience after surgery is different, which means individual patient needs are also different. That is why I customize your treatment plan to best meet your specific needs during recovery. I use EXPAREL® (bupivacaine liposome injectable suspension) because EXPAREL is a non-addictive medication that provides long-lasting pain control directly at the surgical site. Contact me to discuss a pain management plan that is right for you. Visit www.EXPAREL.com/patient for more information.
*The clinical benefit of the decrease in opioid consumption was not demonstrated in the pivotal trials.
EXPAREL® (bupivacaine liposome injectable suspension) is indicated for single-dose infiltration in patients aged 6 years and older to produce postsurgical local analgesia and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks.
Important Safety Information
EXPAREL® (bupivacaine liposome injectable suspension) should not be used in obstetrical paracervical block anesthesia.
In studies in adults where EXPAREL was injected into a wound, the most common side effects were nausea, constipation, and vomiting.
In studies in adults where EXPAREL was injected near a nerve, the most common side effects were nausea, fever, and constipation.
In the study where EXPAREL was given to children, the most common side effects were nausea, vomiting, constipation, low blood pressure, low number of red blood cells, muscle twitching, blurred vision, itching, and rapid heartbeat.
EXPAREL can cause a temporary loss of feeling and/or loss of muscle movement. How much and how long the loss of feeling and/or muscle movement depends on where and how much of EXPAREL was injected and may last for up to 5 days.
EXPAREL is not recommended to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years old for injection near a nerve, and/or in pregnant women.
Tell your health care provider if you or your child has liver disease, since this may affect how the active ingredient (bupivacaine) in EXPAREL is eliminated from the body.
EXPAREL should not be injected into the spine, joints, or veins.
The active ingredient in EXPAREL can affect the nervous system and the cardiovascular system; may cause an allergic reaction; may cause damage if injected into the joints; and can cause a rare blood disorder.
Please refer to the full Prescribing Information here.
For more information, please visit www.EXPAREL.com/patient or call 1-855- 793-9727.